Hikma Pharmaceutical | HIK - DEBITO





DEBITO Cambiamento Data
Almirall EUR 342.86M 61.94M 2025-12
argenx SE USD 47.16M 4.01M 2025-12
AstraZeneca USD 32.24B 1.68B 2026-06
Autolus Therapeutics Ltd USD 253.44M 8.84M 2025-03
Bayer EUR 36.45B 2.93B 2025-12
Fresenius EUR 11.9B 28M 2026-03
Genmab DKK 5.35B 5.2B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 8.52B 1.15B 2026-06
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.04B 86M 2026-03
Orion EUR 330.3M 24.9M 2026-03
Recordati EUR 2.31B 57.06M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12